ArticleThe Journal of clinical endocrinology and metabolism2026
Pregnancy-specific Reference Intervals for TSH and FT4: Novel Insights From Preconception-gestation Longitudinal Data.
Article in The Journal of clinical endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pregnancy-specific Reference Intervals for TSH and FT4: Novel Insights From Preconception-gestation Longitudinal Data.The Journal of clinical endocrinology and metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPregnancy-specific changes in thyroid physiology have prompted the use of pregnancy-specific reference intervals to diagnose thyroid disease. However, such reference intervals are not widely available, and there is no evidence of their superiority over nonpregnancy reference intervals. Preconception data are understudied benchmarks to compare pregnancy-specific and nonpregnancy reference intervals. Moreover, the added value of free T3 (FT3) measurements, for example in cases of (subclinical) hyperthyroidism, remains to be quantified.
methodsThis study was embedded within Generation R Next, a population-based prospective cohort from preconception through postpartum in Rotterdam. Prevalence of thyroid disease entities was assessed using both pregnancy-specific and nonpregnancy reference intervals during pregnancy and using nonpregnancy reference intervals in the preconception period. FT3 concentrations of both euthyroid participants and those with thyroid disease entities were compared in the preconception period and during pregnancy.
resultsThe study population included 1058 women during preconception and 2084 women during pregnancy. The prevalence of subclinical hypothyroidism during pregnancy was 1.5% with the use of nonpregnancy reference intervals and 3.6% with pregnancy-specific reference intervals vs 2.2% during preconception. The prevalence of subclinical hyperthyroidism during pregnancy was 11.1% with the use of nonpregnancy reference intervals and 1.5% with pregnancy-specific reference intervals vs 2.0% during preconception. Additional FT3 measurements reclassified 5.6% of subclinical hyperthyroidism cases to hyperthyroidism during preconception and 14.3% during pregnancy.
conclusionThis is the first study to assess the prevalence of (sub)clinical thyroid disease during pregnancy comparing nonpregnancy and pregnancy-specific reference intervals, while also comparing these prevalences to preconception data from the same source population. We show that pregnancy-specific reference intervals likely result in overdiagnosis of subclinical hypothyroidism and that FT3 has limited value in diagnosing (sub)clinical thyroid disease during pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.